Literature DB >> 34126829

Demographic profile, clinical characteristics and medical management patterns of Indian coronary artery disease patients: a nationwide urban-based, real-world, retrospective, observational electronic medical record study - report of baseline data.

Mohammed Yunus Khan1, Sucheta Pandit1, Santanu Guha2, Uday Jadhav3, M Srinivas Rao4, Kumar Gaurav1, Amey Mane1, Akhilesh Dubey5, Hitendra Bhagwatkar6, Keshavamurthy Venkataswamy7, Snehal Shah8.   

Abstract

Background: This is the first detailed Indian electronic medical record (EMR) based real-world observational study to understand the clinical characteristics, associated comorbidities/risk factors and treatment(s) of CAD patients across India.
Methods: EMR data of adult Indians (aged ≥ 18 years) diagnosed with CAD was retrospectively analyzed.
Results: Majority of the participants had stable IHD (93%), were men (68.5% in ACS, 59.8% in stable IHD), most common age group was 40-64 years in ACS (56.6%) and stable IHD (51.4%). Both are common in metros (ACS 52%, 62% stable IHD). There is a high frequency of hypertension (38.2% in ACS, 59% in stable IHD) and diabetes mellitus (32.3% in ACS, 57.6% in stable IHD). Most common treatments are antiplatelet drugs and lipid-lowering drugs (96%).Conclusions: In India stable IHD is the most prevalent form in vast majority of patients. Patients with CAD are mostly males, are mainly located in metros and majority fall between the age group of 40-64. The major comorbidities are hypertension and diabetes mellitus. Sociodemographic and clinical characteristics for CAD in India may not be similar to what is reported from the west. There is a significant difference in drug usage and adherence to guidelines in India for CAD.

Entities:  

Keywords:  ACS; CAD; IHD; India

Year:  2021        PMID: 34126829     DOI: 10.1080/14779072.2021.1941872

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  1 in total

1.  Correlation of Serum Acylcarnitines with Clinical Presentation and Severity of Coronary Artery Disease.

Authors:  Olga Deda; Eleftherios Panteris; Thomas Meikopoulos; Olga Begou; Thomai Mouskeftara; Efstratios Karagiannidis; Andreas S Papazoglou; Georgios Sianos; Georgios Theodoridis; Helen Gika
Journal:  Biomolecules       Date:  2022-02-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.